Favorable policies ushered in the spring of Chinese patent medicine retail market

[China Pharmaceutical network industry trends] in recent years, the state has successively promulgated a series of favorable policies, such as "two promotion and one relaxation" and "13th five year plan" for the development of traditional Chinese medicine, which have promoted the vigorous development of traditional Chinese medicine and ethnic medicine, and the relevant retail market ushered in the spring Good policy, significant increase of Chinese patent medicine According to the data of minenet, the sales scale of Chinese patent medicine in physical pharmacies in 22 key cities in 2016 was 37.6 billion yuan, up 10.2% year on year, significantly higher than the 8.4% year-on-year growth rate of chemical medicine The market share of Chinese patent medicine has been increasing year by year, accounting for 48.9% of the sales volume of the terminal market of drugs in 22 physical pharmacies in 2016 According to the analysis of drug competition pattern of physical pharmacies in 22 key cities from 2013 to 2016, the proportion of Chinese patent medicines in the western and Central South regions is relatively high, with a large year-on-year increase Among them, the growth rate of Chinese patent medicine in the western region was 14.9% year-on-year, and that in the central and southern region was 13.1% The Central South region includes central China and South China In South China, traditional Chinese medicine is favored due to the influence of history and culture In the western and Central South regions, there are more national pharmaceutical enterprises The market of tonics is very popular Donkey hide gelatin takes the lead in tonifying blood and blood, and it is also a compound donkey hide gelatin, six kinds of rehmannia and kidney treasure for strengthening the waist and kidney, and Yunnan white medicine for injury / hemostasis in the top ten varieties in the four regions Among them, donkey hide gelatin ranks first among the top ten varieties in each region and its market share is relatively high Compound donkey hide gelatin also has outstanding performance in four regions, with a year-on-year growth rate of more than 20% After the implementation of the policy of "two children alone" and the full liberalization of the two child policy, China has ushered in a small peak of the birth rate Ejiao is helpful for the pre pregnancy conditioning, nourishing yin and blood, and creating a healthy pregnancy environment, which has been highly praised Although the retail price of Ejiao keeps rising due to the influence of raw materials, with the improvement of consumption level, the concept of healthy life has changed, and the demand for nourishing health care products is growing, so to a certain extent, it promotes the development of Ejiao industry Cardiovascular and cerebrovascular diseases have obvious regional characteristics of medication Obviously, cardiovascular and cerebrovascular diseases are characterized by "four high and many" diseases Incidence rate is high, disability rate is high, mortality rate is high, recurrence rate is high and complications are many It is a chronic disease which occurs frequently in middle-aged and old people It requires long-term medication and high medical cost Chinese patent medicine has prominent treatment advantages in dredging blood vessels, preventing atherosclerosis and other aspects, and its side effects are relatively small, so it is favored by patients with cardiovascular and cerebrovascular diseases, but the drug selection of patients in different regions is slightly different Angong Niuhuang is listed in the top ten varieties of Chinese patent medicine in the north and Central South regions, and its sales scale in Guangzhou and Beijing is far higher than other cities Beijing Tongrentang and other three enterprises account for more than 90% of the market of Angong Niuhuang In the western region, patients prefer Xuesaitong Local enterprises such as Yunnan peacekeeping Pharmaceutical Co., Ltd occupy 80% of the market of Xuesaitong products, of which Yunnan peacekeeping Pharmaceutical Co., Ltd has a large share, nearly 60% In recent years, due to the influence of air pollution and aging, the prevalence of respiratory diseases is increasing year by year In the traditional Chinese medicine market of physical pharmacies in various regions, the market share of respiratory diseases is high and has advantages Among the four regions, the market share of the eastern region is significantly higher than that of the other three regions, accounting for 26.9%; at the same time, three of the top ten varieties sold in the eastern region belong to respiratory disease drugs, which are antitussive, expectorant, antiasthmatic, Tiepi Fengdou, Jingdu nianci'an honey refining, Chuanbei, loquat and purslane The top ten manufacturers in the four regions are dongajiao and Yunnan Baiyao Both pharmaceutical enterprises are the mainstay of Chinese patent medicine manufacturing enterprises in China, and have made contributions to the development of traditional Chinese medicine industry for many years Dong'ejiao is a leading enterprise in the market of Invigorating Qi and replenishing blood Through long-term accumulation, it has formed a stable strategic cooperation relationship with the top 100 chains The terminal sales of Ejiao series products (Ejiao and compound Ejiao) have been growing steadily year by year, ranking first among the top 10 manufacturers in each region Yunnan Baiyao products are mainly involved in four categories of injury, heat clearing and detoxification, hemostasis and cold, among which Yunnan Baiyao series are the main products In 2016, Yunnan Baiyao introduced the development thought of "double creation" and "Internet plus" In further consolidating the channels, it promoted the marketing transformation of multi-channel and new models, promoted the combination of online product sales and offline services, and played the advantage of sales and service in traditional channels, effectively promoting the growth of product sales The geographical advantages of Zhejiang emperor and Taiji group are obvious as the local enterprises in the eastern region The pharmaceutical industry of Zhejiang emperor specializes in the cultivation, research and development, production and marketing of precious Chinese herbal medicine Dendrobium candidum In 2016, Zhejiang emperor Pharmaceutical Co., Ltd ranked among the top ten manufacturers in the eastern region by virtue of its excellent performance of Tiepi Fengdou granules Tiepi Fengdou granules accounted for 10.3% of the eastern respiratory disease drug market annually, far higher than the second place in the market of nanci'an honey refined Chuanbei loquat cream in Kyoto, with prominent terminal advantages Taiji Group has three enterprises listed in the top ten manufacturers in the West Taiji Group has cultivated the Sichuan Chongqing market for many years, actively promoted the academic marketing of medical products, started the key and characteristic sales mode, and achieved remarkable results in Sichuan Chongqing area In 2016, in the western region, the sales scale of Taiji three enterprises has a double-digit growth, with a total market share of 8.7%, reaching the first dong'a-jiao Data source: competition pattern of terminal of Chinese patent medicine in retail pharmacies in key cities, city version of minenet sample Note: the original title of 22 key city area division: obvious rise of proprietary Chinese medicine top 10 varieties in four areas are exposed to teach you to use app (Pharma) in the whole process to seize the opportunity of pharmaceutical machinery